Hematopoietic Stem Cell Transplantation (HSCT) for Children With SCID Utilizing Alemtuzumab, Plerixafor & Filgrastim

This study has been terminated.
(Insufficient evidence of efficacy)
Sponsor:
Information provided by (Responsible Party):
Christopher Dvorak, University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT01182675
First received: August 9, 2010
Last updated: May 16, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: September 2013
  Estimated Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)